Literature DB >> 21878976

Anticancer Drugs: Selective oxycution?

Darren J Burgess.   

Abstract

Year:  2011        PMID： 21878976     DOI： 10.1038/nrd3543

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  1 in total

1.  Selective killing of cancer cells by a small molecule targeting the stress response to ROS.

Authors:  Lakshmi Raj; Takao Ide; Aditi U Gurkar; Michael Foley; Monica Schenone; Xiaoyu Li; Nicola J Tolliday; Todd R Golub; Steven A Carr; Alykhan F Shamji; Andrew M Stern; Anna Mandinova; Stuart L Schreiber; Sam W Lee
Journal:  Nature       Date:  2011-07-13       Impact factor: 49.962
  1 in total
  3 in total

1.  Mitochondrial dysfunction enhances cisplatin resistance in human gastric cancer cells via the ROS-activated GCN2-eIF2α-ATF4-xCT pathway.

Authors:  Sheng-Fan Wang; Meng-Shian Chen; Yueh-Ching Chou; Yune-Fang Ueng; Pen-Hui Yin; Tien-Shun Yeh; Hsin-Chen Lee
Journal:  Oncotarget       Date:  2016-11-08

Review 2.  Emerging Anticancer Potentials of Selenium on Osteosarcoma.

Authors:  Kok-Lun Pang; Kok-Yong Chin
Journal:  Int J Mol Sci       Date:  2019-10-25       Impact factor: 5.923

3.  Piperlongumine induces autophagy by targeting p38 signaling.

Authors:  Y Wang; J-W Wang; X Xiao; Y Shan; B Xue; G Jiang; Q He; J Chen; H-G Xu; R-X Zhao; K D Werle; R Cui; J Liang; Y-L Li; Z-X Xu
Journal:  Cell Death Dis       Date:  2013-10-03       Impact factor: 8.469
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.